Company: DMAAR
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001213900-25-026240
Chunk: 801

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 9A
Chunk 801
---
 charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of
the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) transfers by private sales or
transfers made in connection with consummation of a business combination at prices no greater than the price at which the securities were
originally purchased; (f) in the event of our liquidation prior to our completion of our initial business combination; (g) by virtue of
the laws of Delaware or our sponsor’s limited liability company agreement, as amended, upon dissolution of our sponsor; (h) in the
event of our completion of a liquidation, merger, share exchange, reorganization or other similar transaction which results in all of
our public shareholders having the right to exchange their ordinary shares for cash, securities or other property subsequent to our completion
of our initial business combination; or (i) to a nominee or custodian of a person or entity to whom a disposition or transfer would be
permissible under clauses (a) through (h) above; provided, however, that in the case of clauses (a) through (e) and (i) these permitted
transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained
in the letter agreement. In addition, we could agree to permit the holders of our founder shares to transfer shares or agree to cancel
such securities. Although no such transfers or cancellations are contemplated, we could agree to permit such transfer or cancellation
to facilitate the closing of a business combination. Any permitted transferees would be subject to the same restrictions and other agreements
of our initial shareholders with respect to any founder shares. However, if after a business combination there is a transaction whereby
all the outstanding shares are exchanged or redeemed for cash (as would be the case in a post-asset sale liquidation) or another issuer’s
shares then the founder shares and the Private Placement Units (or any ordinary shares underlying thereunder) shall be permitted to participate.

23

Registration Rights

The holders of the
founder shares, Private Placement Units (and underlying securities) and any units (and underlying securities) that may be issued on
conversion of working capital loans will be entitled to registration rights pursuant to a registration rights agreement requiring us
to register such securities for resale. The holders of these securities will be entitled to make up to three demands,